Tenax Therapeutics Inc (NASDAQ: TENX) started the day on Wednesday, with a price increase of 21.40% at $18.27, before settling in for the price of $15.05 at the close. Taking a more long-term approach, TENX posted a 52-week range of $4.63-$15.58.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 77.86%. Meanwhile, its Annual Earning per share during the time was 77.86%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -19.37%. This publicly-traded company’s shares outstanding now amounts to $5.91 million, simultaneously with a float of $4.79 million. The organization now has a market capitalization sitting at $114.08 million.
Tenax Therapeutics Inc (TENX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Tenax Therapeutics Inc’s current insider ownership accounts for 23.35%, in contrast to 87.90% institutional ownership. According to the most recent insider trade that took place on Dec 09 ’25, this organization’s Chief Medical Officer bought 2,500 shares at the rate of 10.22, making the entire transaction reach 25,542 in total value, affecting insider ownership by 5,266. Preceding that transaction, on Dec 08 ’25, Company’s Chief Medical Officer bought 2,500 for 10.10, making the whole transaction’s value amount to 25,250. This particular insider is now the holder of 5,000 in total.
Tenax Therapeutics Inc (TENX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
Tenax Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -19.37% and is forecasted to reach -2.75 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -27.39% through the next 5 years, which can be compared against the 77.86% growth it accomplished over the previous five years trading on the market.
Tenax Therapeutics Inc (NASDAQ: TENX) Trading Performance Indicators
Let’s observe the current performance indicators for Tenax Therapeutics Inc (TENX). It’s Quick Ratio in the last reported quarter now stands at 15.58.
In the same vein, TENX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.13, a figure that is expected to reach -0.41 in the next quarter, and analysts are predicting that it will be -2.75 at the market close of one year from today.
